We are live on ! Find out more
PRPH

ProPhase Labs
PRPH

Delisted

PRPH was delisted on the 2nd of January, 2026.

Back to rankings

13 hedge funds and large institutions have $989K invested in ProPhase Labs in 2019 Q4 according to their latest regulatory filings, with 1 funds opening new positions, 3 increasing their positions, 2 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

50% more repeat investments, than reductions

Existing positions increased: 3 | Existing positions reduced: 2

2% more capital invested

Capital invested by funds: $966K → $989K (+$23K)

0% less ownership

Funds ownership: 0.44% → 0.44% (-0%)

7% less funds holding

Funds holding: 14 → 13 (-1)

50% less first-time investments, than exits

New positions opened: 1 | Existing positions closed: 2

Holders
13
Holders Change
-1
Holders Change %
-7.14%
% of All Funds
0.26%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
3
Reduced
2
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Commonwealth Equity Services
Commonwealth Equity Services
Massachusetts
+$3.25K
2
Renaissance Technologies
Renaissance Technologies
New York
+$1.96K
3
UBS Group
UBS Group
Switzerland
+$254
4
TRCT
Tower Research Capital (TRC)
New York
+$235

Top Sellers

Rank Fund Capital Flow
1
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$4.7K
2
Victory Capital Management
Victory Capital Management
Texas
-$3K
3
Bank of America
Bank of America
North Carolina
-$98
4
Northern Trust
Northern Trust
Illinois
-$20

PRPH Hedge Fund Activity: Q4 2019 in Review

13 of the 5,092 institutional investors tracked by Wall St. Rank reported a position in ProPhase Labs (PRPH) for Q4 2019, worth a combined $989K — up 2.4% from $966K a quarter earlier.

Sellers outnumbered buyers: 2 funds closed out of PRPH and 1 opened new positions — a net loss of 1 holder — while 2 trimmed existing stakes and 3 added.

The largest buyer was Commonwealth Equity Services, adding an estimated $3.25K. The largest seller was Susquehanna International Group, cutting an estimated $4.7K.

  • 13 institutional investors held ProPhase Labs (PRPH) as of Q4 2019, down from 14 in Q3 2019.
  • Funds reported $989K of ProPhase Labs stock for Q4 2019, up 2.4% quarter-over-quarter.
  • 1 fund opened new ProPhase Labs positions in Q4 2019 and 2 closed out, a net change of -1 holder.
  • The largest ProPhase Labs buyer in Q4 2019 was Commonwealth Equity Services, an estimated $3.25K added.
  • The largest ProPhase Labs seller in Q4 2019 was Susquehanna International Group, an estimated $4.7K sold.

Based on aggregated 13F filings for Q4 2019.